This inventor holds 3 USPTO granted patents. Top assignees: Otsuka Pharmaceutical Company, Limited, Glytech, Inc.. Active years: 1991-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-2013
Title: Yoshiyasu Fukuyama: Innovator in Neurotrophic Compounds
Introduction
Yoshiyasu Fukuyama is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of neurotrophic compounds, holding a total of 3 patents. His work focuses on enhancing neurotrophic factor activity, which has important implications for medical science.
Latest Patents
Fukuyama's latest patents include a bis(tetrahydrofuran) compound, a method for its production, and its use. This innovative compound is designed to enhance neurotrophic factor activity, which is crucial for nerve health. The compound is represented by a specific chemical formula, where various groups can be substituted to optimize its effectiveness. Additionally, he has developed 1,4-benzoquinone derivatives and benzene derivatives that improve cerebral and cardiac blood flow, offering potential treatments for heart failure and cerebral ischemia with low toxicity.
Career Highlights
Throughout his career, Fukuyama has worked with prominent companies such as Otsuka Pharmaceutical Company and Glytech, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in medical treatments.
Collaborations
Fukuyama has collaborated with notable colleagues, including Hideyuki Iwaki and Tatsuyoshi Tanaka. These partnerships have fostered a collaborative environment that encourages innovation and the development of new therapeutic solutions.
Conclusion
Yoshiyasu Fukuyama's work in neurotrophic compounds and his collaborations with leading companies and colleagues highlight his significant impact on the field. His inventions continue to pave the way for advancements in medical science and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

